Related Experiment Video
Updated: Jun 3, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Streptococcus pneumoniae Serotype Distribution Among US Adults Hospitalized With Community-Acquired Pneumonia,
Julio A Ramirez1,2, Robin A Hubler3, Mohammad Ali3
1Norton Infectious Diseases Institute, Norton Healthcare, Louisville, Kentucky, USA.
Pneumococcal conjugate vaccines (PCVs) serotypes caused significant community-acquired pneumonia (CAP) in US adults, even during the COVID-19 pandemic. Urinary antigen detection assays help guide PCV recommendations for preventing pneumococcal disease.
Area of Science:
- Infectious Diseases
- Vaccinology
- Epidemiology
Background:
- Community-acquired pneumonia (CAP) remains a significant public health concern in adults.
- Streptococcus pneumoniae is a leading cause of CAP, with serotype distribution influencing vaccine recommendations.
- Urinary antigen detection (UAD) assays offer a method for serotype-specific diagnosis of pneumococcal CAP.
Purpose of the Study:
- To estimate the contribution of Streptococcus pneumoniae serotypes covered by current and emerging pneumococcal conjugate vaccines (PCVs) in hospitalized adults with CAP.
- To assess the impact of the COVID-19 pandemic on the prevalence of vaccine-preventable pneumococcal serotypes causing CAP.
- To provide data for informing updated PCV recommendations in the United States.
Main Methods:
- Prospective enrollment of adults hospitalized with radiographic evidence of CAP across four US cities from November 2019 to December 2020.
- Collection of clinical data through patient interviews and medical chart reviews.
- Detection of Streptococcus pneumoniae using standard respiratory samples and blood, alongside per-protocol urine testing with BinaxNOW and UAD assays to identify specific serotypes covered by PCV13, PCV15, and PCV20.
Main Results:
- Of 2105 adults with radiographically confirmed CAP, 10.2% tested positive for Streptococcus pneumoniae.
- Pneumococcal serotypes covered by PCV13, PCV15, and PCV20 were detected in 3.0%, 3.9%, and 5.7% of participants, respectively.
- The detection rates of Streptococcus pneumoniae and PCV serotypes were higher in the pre-pandemic period (November 2019-April 2020) compared to the pandemic period (May 2020-December 2020).
Conclusions:
- Despite the COVID-19 pandemic, Streptococcus pneumoniae serotypes covered by PCVs continue to be a significant cause of adult CAP in the US.
- The findings underscore the importance of serotype-specific data for guiding PCV recommendations.
- This study establishes an epidemiologic baseline to evaluate the future impact of PCV recommendations on pneumococcal disease burden.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:

